Crown Advisors Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,500
| Closed | -$568K | – | 47 |
|
|
2023
Q2 | $568K | Hold |
1,500
| – | – | 0.37% | 51 |
|
|
2023
Q1 | $718K | Hold |
1,500
| – | – | 0.54% | 44 |
|
|
2022
Q4 | $630K | Hold |
1,500
| – | – | 0.57% | 41 |
|
|
2022
Q3 | $625K | Hold |
1,500
| – | – | 0.62% | 40 |
|
|
2022
Q2 | $742K | Hold |
1,500
| – | – | 0.68% | 41 |
|
|
2022
Q1 | $844K | Hold |
1,500
| – | – | 0.59% | 43 |
|
|
2021
Q4 | $1.13M | Hold |
1,500
| – | – | 0.73% | 37 |
|
|
2021
Q3 | $1.12M | Hold |
1,500
| – | – | 0.79% | 37 |
|
|
2021
Q2 | $966K | Hold |
1,500
| – | – | 0.67% | 37 |
|
|
2021
Q1 | $857K | Hold |
1,500
| – | – | 0.67% | 37 |
|
|
2020
Q4 | $874K | Hold |
1,500
| – | – | 0.63% | 35 |
|
|
2020
Q3 | $773K | Hold |
1,500
| – | – | 0.5% | 41 |
|
|
2020
Q2 | $677K | Hold |
1,500
| – | – | 0.46% | 41 |
|
|
2020
Q1 | $526K | Buy |
+1,500
| New | +$526K | 0.42% | 40 |
|